Our Story
When APC was formed in 2011, it was poised to be a game changer in process development. And as it has grown, it has also evolved, leading to the creation of VLE, which is hyper-accelerating the path of specialized medicines to market. Here is a brief overview of our story.
.png)
Setting Forth
A Leap of Faith
From the very beginning, our vision has been to revolutionize CMC practices through science and innovation. We began with a single, brave client who saw the passion in Mark and Brian, and put their faith in them to prove what was possible.
fact box
.svg)
.png)
Breaking Through
Leading with Innovation
We quickly made a name for ourselves by providing innovative solutions to some of the most complex and chronic problems in process development.
From self-optimizing bioreactors to simulated mixing environments, APC has developed a host of extraordinary breakthroughs for clients.
VLE Quiz
APC’s first research project in 2011 solved a manufacturing throughput problem for a medicine that treated which area of illness?
.png)
High-Powered Process Development
Pioneering the Use of Microcarriers
Our process development expertise never settles for existing methods, especially if it means potential life-saving therapies won’t reach patients fast enough. Making clients’ gene therapies, viral vaccines and viral immunotherapies commercially viable required the development of multiple novel approaches using microcarrier beads in single-use bioreactors.
Read MoreDigital Transparency
Our Process at Your Fingertips
There are no smoke and mirrors with APC & VLE. From process development through manufacturing, clients have total clarity with iACHIEVE, our collaborative knowledge management platform for ongoing and transparent communication and robust digital documentation. iACHIEVE turns typically painstaking tech transfers into effortless onramps to manufacturing and regulatory review.
.png)
fact box
team
fact box
.svg)
On the Global Stage
Next-Generation Vaccine Development
At the start of the pandemic, we were eager to assist the global community by expediting the development of a coronavirus vaccine. An Taoiseach Micheál Martin visited visited APC and VLE to tour our state-of-the-art facility, meet our team of world-class scientists and manufacturing engineers, and promote Ireland’s global standing.
VLE Quiz
At VLE’s inception how many nationalities were working across our combined APC & VLE teams?
Beyond Process Development
INTERVIEW
VLE: The Medicine Accelerator
Years of optimizing and perfecting process development have surfaced critical flaws in manufacturing. So we created VLE to combine forces with APC, creating a true medicine accelerator that slashes the timeline to patients by utilizing an adaptive, flexible manufacturing approach rather than pre-set, standardized methods.
Read The Interviewfact box
Cap
from Platforms and
Customers
for CGT & Vaccines
Tech based Manufacture
fact box
.svg)
VLE Changes the Game
INTERVIEW
Science-Led Manufacturing
VLE is eliminating traditional tech transfer by having our scientists and engineers lead the knowledge transfer into manufacturing. Every day we strive to recognize opportunities to create a more streamlined flow from process development to manufacturing, ultimately accelerating the delivery to patients.
Read The InterviewVLE Quiz
The laboratories in our state of the art facility are all named after what?
.png)
Looking Forward
.png)
Extending the Value Chain
With APC at the helm of process development, VLE extends the value chain for our clients by accelerating GMP manufacturing through all phases of clinical trials. We’re reducing costs and shortening timelines while optimizing manufacturing for trials. Our motivation isn’t filling tanks—it’s changing lives.
.jpg)